Michael Biddlecom

Michael Biddlecom is a seasoned executive in market access and pricing strategy, currently serving as VP, Head of Market Access at Orphalan since March 2023, where leadership extends to patient services, payer engagement, and strategic pricing for a rare disease start-up. Prior roles include Senior Director of Access Strategy and Pricing and Senior Director of Pricing & Contracting at Oyster Point Pharma, contributing to launch pricing and contract analysis. Michael held the position of Head of Strategic Pricing & Contracting at AMAG Pharmaceuticals, driving strategic initiatives post-acquisition by Covis Pharma. At Sunovion Pharmaceuticals, leadership involved pricing analysis and health policy modeling, while at Sanofi Genzyme, significant contributions were made in pricing and contract strategies for oncology and immunology products. Previous experience also includes critical roles at Biogen and Aker Kvaerner, complemented by an MBA from Northwestern University's Kellogg School of Management and a BS in Chemical Engineering from Bucknell University.